Japer Therapeutics Warrants
JSPRW
14 hedge funds and large institutions have $55.5K invested in Japer Therapeutics Warrants in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.46% less ownership
Funds ownership: 3.91% → 3.45% (-0.46%)
59% less capital invested
Capital invested by funds: $135K → $55.5K (-$79.5K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$4 |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCAM
Owl Creek Asset Management
New York
|
-$4.73K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$1.81K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| 4 |
HF
HRT Financial
New York
|
-$305 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Highbridge Capital Management
New York
| $16K | – | – | – |
|
|
ICM
2
Ionic Capital Management
New York
| $13.8K | – | – | – |
|
|
OCAM
3
Owl Creek Asset Management
New York
| $8.02K | -$4.73K | -107,644 | -29% |
|
|
TCM
4
Tenor Capital Management
New York
| $7.5K | – | – | – |
|
|
PFM
5
Privium Fund Management
Amsterdam,
Netherlands
| $3.33K | +$4 | +100 | +0.1% |
|
|
ZA
6
Zazove Associates
Incline Village,
Nevada
| $2K | – | – | – |
|
|
EPM
7
Equitec Proprietary Markets
Chicago,
Illinois
| $1.38K | – | – | – |
|
|
SCM
8
Shaolin Capital Management
Miami,
Florida
| $1K | -$1.81K | -41,222 | -67% |
|
|
CAC
9
Cowen and Company
New York
| $977 | – | – | – |
|
10
Walleye Capital
New York
| $752 | – | – | – |
|
11
Walleye Trading
New York
| $423 | – | – | – |
|
|
WAM
12
Wolverine Asset Management
Chicago,
Illinois
| $319 | – | – | – |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$1K | -19,296 | Closed |
|
|
HF
14
HRT Financial
New York
| – | -$305 | -6,940 | -24% |
|
|
15
Osaic Holdings
Scottsdale,
Arizona
| – | +$2 | +50 | New |
|
JSPRW Hedge Fund Activity: Q4 2022 in Review
14 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q4 2022, worth a combined $55.5K — down 59% from $135K a quarter earlier.
Fund positioning in JSPRW was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Privium Fund Management, adding an estimated $4. The largest seller was Owl Creek Asset Management, cutting an estimated $4.73K.
- 14 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $55.5K of Japer Therapeutics Warrants stock for Q4 2022, down 59% quarter-over-quarter.
- 1 fund opened new Japer Therapeutics Warrants positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest Japer Therapeutics Warrants buyer in Q4 2022 was Privium Fund Management, an estimated $4 added.
- The largest Japer Therapeutics Warrants seller in Q4 2022 was Owl Creek Asset Management, an estimated $4.73K sold.
Based on aggregated 13F filings for Q4 2022.